Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von SpringheelJack 

Metlife Inc. diskutieren

Metlife Inc.

WKN: 934623 / Symbol: MET / Name: MetLife / Aktie / Versicherungen / Large Cap /

70,26 €
0,41 %

Einschätzung Buy
Rendite (%) 5,31 %
Kursziel 80,19
Veränderung
Endet am 09.07.26

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Keefe, Bruyette & Woods from $95.00 to $94.00. They now have an "outperform" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 4,29 %
Kursziel 82,61
Veränderung
Endet am 10.07.26

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Wells Fargo & Company from $94.00 to $97.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

MetLife, Inc. (NYSE: MET) had its "overweight" rating re-affirmed by analysts at Morgan Stanley.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 10,94 %
Kursziel 78,03
Veränderung
Endet am 07.08.26

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at UBS Group AG from $94.00 to $91.00. They now have a "buy" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 7,76 %
Kursziel 88,30
Veränderung
Endet am 11.08.26

MetLife, Inc. (NYSE: MET) had its price target raised by analysts at Jefferies Financial Group Inc. from $100.00 to $103.00. They now have a "buy" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 6,63 %
Kursziel 80,32
Veränderung
Endet am 18.08.26

MetLife, Inc. (NYSE: MET) had its price target lowered by analysts at Morgan Stanley from $98.00 to $94.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

MetLife (NYSE:MET) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) -1,08 %
Kursziel 82,92
Veränderung
Endet am 07.10.26

MetLife (NYSE:MET) had its price target raised by analysts at Morgan Stanley from $94.00 to $97.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) -0,97 %
Kursziel 84,29
Veränderung
Endet am 08.10.26

MetLife (NYSE:MET) had its "overweight" rating reaffirmed by analysts at Barclays PLC. They now have a $98.00 price target on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) -0,93 %
Kursziel 82,57
Veränderung
Endet am 08.10.26

MetLife (NYSE:MET) had its price target raised by analysts at Wells Fargo & Company from $95.00 to $96.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 6,75 %
Kursziel 82,55
Veränderung
Endet am 06.11.26

MetLife (NYSE:MET) had its price target lowered by analysts at UBS Group AG from $96.00 to $95.00. They now have a "buy" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 7,19 %
Kursziel 79,74
Veränderung
Endet am 07.11.26

MetLife (NYSE:MET) had its price target lowered by analysts at Wells Fargo & Company from $96.00 to $92.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 4,62 %
Kursziel 77,90
Veränderung
Endet am 11.11.26

MetLife (NYSE:MET) had its price target lowered by analysts at Keefe, Bruyette & Woods from $92.00 to $90.00. They now have an "outperform" rating on the stock.
Ratings data for MET provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,00 %
Kursziel 86,03
Veränderung
Endet am 15.12.26

MetLife (NYSE:MET) was given a new $101.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat